Decision aids that support decisions about prenatal testing for Down syndrome: an environmental scan.

BMC Med Inform Decis Mak

Research Axis of Population Health and Practice-Changing Research, CHU de Québec Research Centre, Saint-François-d'Assise Hospital, 10, rue de l'Espinay, Quebec, QC, G1L 3L5, Canada.

Published: September 2015

Background: Prenatal screening tests for Down syndrome (DS) are routine in many developed countries and new tests are rapidly becoming available. Decisions about prenatal screening are increasingly complex with each successive test, and pregnant women need information about risks and benefits as well as clarity about their values. Decision aids (DAs) can help healthcare providers support women in this decision. Using an environmental scan, we aimed to identify publicly available DAs focusing on prenatal screening/diagnosis for Down syndrome that provide effective support for decision making.

Methods: Data sources searched were the Decision Aids Library Inventory (DALI) of the Ottawa Patient Decision Aids Research Group at the Ottawa Health Research Institute; Google searches on the internet; professional organizations, academic institutions and other experts in the field; and references in existing systematic reviews on DAs. Eligible DAs targeted pregnant women, focused on prenatal screening and/or diagnosis, applied to tests for fetal abnormalities or aneuploidies, and were in French, English, Spanish or Portuguese. Pairs of reviewers independently identified eligible DAs and extracted characteristics including the presence of practical decision support tools and features to aid comprehension. They then performed quality assessment using the 16 minimum standards established by the International Patient Decision Aids Standards (IPDASi v4.0).

Results: Of 543 potentially eligible DAs (512 in DALI, 27 from experts, and four on the internet), 23 were eligible and 20 were available for data extraction. DAs were developed from 1996 to 2013 in six countries (UK, USA, Canada, Australia, Sweden, and France). Five DAs were for prenatal screening, three for prenatal diagnosis and 12 for both). Eight contained values clarification methods (personal worksheets). The 20 DAs scored a median of 10/16 (range 6-15) on the 16 IPDAS minimum standards.

Discussion: None of the 20 included DAs met all 16 IPDAS minimum standards, and few included practical decision support tools or aids to comprehension.

Conclusions: Our results indicate there is a need for DAs that effectively support decision making regarding prenatal testing for Down syndrome, especially in light of the recently available non-invasive prenatal screening tests.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583147PMC
http://dx.doi.org/10.1186/s12911-015-0199-6DOI Listing

Publication Analysis

Top Keywords

decision aids
20
prenatal screening
20
eligible das
12
das
11
decision
10
prenatal
9
decisions prenatal
8
prenatal testing
8
testing syndrome
8
environmental scan
8

Similar Publications

Background: Patients supported by extracorporeal membrane oxygenation (ECMO) are at a high risk of brain injury, contributing to significant morbidity and mortality. This study aimed to employ machine learning (ML) techniques to predict brain injury in pediatric patients ECMO and identify key variables for future research.

Methods: Data from pediatric patients undergoing ECMO were collected from the Chinese Society of Extracorporeal Life Support (CSECLS) registry database and local hospitals.

View Article and Find Full Text PDF

Modeling suction of unsaturated granular soil treated with biochar in plant microbial fuel cell bioelectricity system.

Sci Rep

January 2025

Departamento de Ciencias de la Construcción, Facultad de Ciencias de la Construcción Ordenamiento Territorial, Universidad Tecnológica Metropolitana, Santiago, Chile.

There is an initiative driven by the carbon-neutrality nature of biochar in recent times, where various countries across Europe and North America have introduced perks to encourage the production of biochar for construction purposes. This objective aligns with the zero greenhouse emission targets set by COP27 for 2050. This research work seeks to assess the effectiveness of biochar in soils with varying grain size distributions in enhancing the soil-water characteristic curve (SWCC).

View Article and Find Full Text PDF

Effectiveness of shared decision making strategies for stroke prevention among patients with atrial fibrillation: cluster randomized controlled trial.

BMJ

January 2025

Department of Population Health Sciences, University of Utah, Salt Lake City VA Informatics, Decision-Enhancement and Analytic Sciences, Salt Lake City, UT, USA.

Objective: To evaluate the effectiveness of multiple decision aid strategies in promoting high quality shared decision making for prevention of stroke in patients with non-valvular atrial fibrillation.

Design: Cluster randomized controlled trial.

Setting: Six academic medical centers in the United States.

View Article and Find Full Text PDF

AQuA-P: A machine learning-based tool for water quality assessment.

J Contam Hydrol

January 2025

Department of Computer Science, Instituto Nacional de Astrofísica, Optica y Electrónica, Luis Enrique Erro 1, Tonantzintla, 72840 Puebla, México; Consejo Nacional de Humanidades, Ciencias y Tecnologías (Conahcyt), Insurgentes Sur 1582, Mexico City 03940, Mexico. Electronic address:

This study addresses the critical challenge of assessing the quality of groundwater and surface water, which are essential resources for various societal needs. The main contribution of this study is the application of machine learning models for evaluating water quality, using a national database from Mexico that includes groundwater, lotic (flowing), lentic (stagnant), and coastal water quality parameters. Notably, no comparable water quality classification system currently exists.

View Article and Find Full Text PDF

A comprehensive review of computational diagnostic techniques for lymphedema.

Prog Biomed Eng (Bristol)

January 2025

Amrita Vishwa Vidyapeetham, Center for Wireless Networks & Applications (WNA), Amrita Vishwa Vidyapeetham Amritapuri, Kollam, India, Kollam, 690525, INDIA.

Lymphedema is localized swelling due to lymphatic system dysfunction, often affecting arms and legs due to fluid accumulation. It occurs in 20% to 94% of patients within 2 to 5 years after breast cancer treatment, with around 20% of women developing breast cancer-related lymphedema (BCRL). This condition involves the accumulation of protein-rich fluid in interstitial spaces, leading to symptoms like swelling, pain, and reduced mobility that significantly impact quality of life.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!